Skip to main content

Hochman David P's Form 4 filing

Orchestra BioMed Holdings, Inc. (OBIO) · filed Aug 4, 2025

Accession no.
0001104659-25-073743
Filed
Aug 4, 2025
Trade date
Aug 4, 2025
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market purchases total $55.0K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hochman David PCIK 0001292834Director, Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 4, 2025Common Stock, par value $0.0001 per share ("Common Stock")PPurchaseAcquired+20,000$2.75F1+$55,000349,331Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $2.75 per share.

Referenced by the price of 1 transaction in Table I.

Remarks

Chief Executive Officer and Chairperson

Read the full filing on SEC EDGAR (opens in a new tab)